Yue Wannianqing Co., Ltd.

Announcement on the Completion of Share Reduction Plan by Shareholders

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Legal Opinion from Guohao Law Firm (Guangzhou) Regarding the 2025 Annual Shareholders' Meeting of Guangdong Wannianqing Pharmaceutical Co., Ltd.

Announcement on the Company's Reappointment of the Accounting Firm for the Year 2026

Announcement on the Company's Compensation Plan for Directors and Senior Management for the Year 2026

Announcement on Changing the Head of the Company's Internal Audit Department

Board of Directors Work Report for the Year 2025

Independent Director Work Report for the Year 2025 (Guo Jian)

Independent Director Work Report for the Year 2025 (Li Huaqing)

Independent Director Work Report for the Year 2025 (Yang Xueru)

Notice on Holding the 2025 Annual and First Quarter 2026 Online Performance Briefing

Internal Control Audit Report for the Year 2025

Self-Evaluation Report on Internal Control for the Year 2025

Compensation Management System for Directors and Senior Management

Announcement on Changes in the Company's Accounting Policies

Announcement on the Company's Provision for Credit Impairment and Asset Impairment for the Year 2025

Announcement on Increasing the Estimated Daily Related Transactions for the Year 2026

Notice on the Convening of the 2025 Annual Shareholders' Meeting

Resolution Announcement of the 11th Meeting of the 3rd Board of Directors

Announcement on the Profit Distribution Plan for the Year 2025

Quarterly Report for the First Quarter of 2026

Special Report on the Storage and Actual Use of Raised Funds for the Year 2025

Verification Opinion by Guolian Minsheng Securities Underwriting and Sponsorship Co., Ltd. on the Storage and Actual Use of Raised Funds of Guangdong Wannianqing Pharmaceutical Co., Ltd. for the Year 2025

Verification Report on the Storage, Management, and Use of Raised Funds of Guangdong Wannianqing Pharmaceutical Co., Ltd. by Huaxing Accounting Firm (Special General Partnership)

Special Verification Opinion by Huaxing Accounting Firm (Special General Partnership) on the Deduction of Operating Income of Guangdong Wannianqing Pharmaceutical Co., Ltd. for the Year 2025

Evaluation Report on the Performance of the Accounting Firm for the Year 2025 and the Report on the Audit Committee's Supervision Responsibilities

Special Explanation by Huaxing Accounting Firm (Special General Partnership) on the Non-Operating Fund Occupation and Other Related Fund Transactions of Guangdong Wannianqing Pharmaceutical Co., Ltd. for the Year 2025

Special report of the board of directors on the self-examination of the independence of independent directors

2025 annual audit report

2025 annual report

Summary of the 2025 annual report